Decrease Caregiving Fatigue in Group Leaders of a Support Group for Women After Cancer
Condition(s) studied
Investigational drug(s) / intervention(s)
Self-compassion training: Online group intervention: led by a certified mindfulness teacher for mindful self-compassion and additional qualification in self-compassion in healthcare communities (duration: 6 weekly appointments of 90 min each);
Study summary
This exploratory study aims to evaluate the effect of a self-compassion training developed for health professionals on leaders of self-help groups.
Hypothesis/primary goal: An online group intervention adapted from the "Self-compassion for health-care communities program" validated for health professionals leads to an increase in self-compassion among leaders of cancer self-help groups. Secondary goals: level of self-compassion at the end of the course as a mediator for therapeutic variables after 6 weeks, decrease in caregiver fatigue, secondary traumatic stress/burnout risk, personal distress and sick leave, decrease in fears of self-compassion/compassion for others; increase in mindfulness, self-efficacy, compassion for others and resilience; direct costs; safety;
Intervention:
Online group intervention: led by a certified mindfulness teacher for Mindful Self-Compassion and additional qualification in Self-Compassion in Healthcare Communities (duration: 6 weekly appointments of 90 min each); control intervention: waiting group
Eligibility
Primary outcome measure(s)
- self-compassion as assessed by Self-compassion scale in german version (SCS-D) — 6 weeks after baseline
Determining self-compassion after the intervention by means of a confirmatory test for group differences in the primary endpoint according to the ITT principle using a linear regression model; instrument: SCS-D
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Comprehensive Cancer Center Würzburg | Würzburg | Bavaria |
More Wuerzburg University Hospital trials in Germany
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06937606 on ClinicalTrials.gov ↗ ← All trials in Germany